Pharmacodynamics 1 Flashcards
Identify molecular targets for drug action
receptors, ion channels, enzymes and transporters
Drug interactions with target depend on two factors:
- Shape - this determines the ability of the drug to bind - ‘lock and key’ mechanism
- Charge distribution - this determines the type of bonds that holds the drug to the target
weakest ——–> strongest
van der Waals forces < hydrogen bonds < ionic interactions < covalent bonds
Define the terms agonist, antagonist and partial agonist
Agonist A ligand (a drug or an endogenous molecule e.g. neurotransmitter, hormone) that binds to a receptor to elicit a cellular response.
Antagonist
A drug which binds to a receptor and inhibits the receptor from responding to the endogenous ligand.
Partial agonist
Cannot evoke maximum response the system is capable of producing, even when occupying all the available receptors
Define the terms affinity, efficacy and potency
Affinity describes the strength with which a ligand binds to a receptor. A high affinity drug has a much greater tendency to bind to the receptor relative to its dissociation from the receptor
Kd = equilibrium dissociation constant = measure of affinity
Efficacy
= Emax = the maximum effect
the drug can elicit)
Potency = the concentration of drug needed to produce an effect
Pharmacodynamics is
the effect of a drug on the body
- Mechanism of action of drugs
- Targets for drug action
- How drugs act at the target
- How the drug produces an action within a cell - Influence of drug concentration on the magnitude of response
- Graphical representation of concentration-effect relationships
- Therapeutic versus toxic effects
Example of an agonist
e.g. epinephrine/adrenaline acts as an agonist at the β1 adrenoreceptor in the heart to increase cardiac output.
Example of an antagonist
e.g. bisoprolol acts as an antagonist at the β1 adrenoreceptor in the heart to decrease cardiac output
Receptors within a given family generally occur in several molecular varieties (subtypes)
They have similar structure but significant differences in their sequences, and often in their pharmacological properties
Identified either:
- On the basis of selectivity of agonists and/or antagonists
- Or by cloning techniques
explain the different receptor subtypes for adrenoceptors
a1 =
ag epin
anta doxazosin
b1 =
ag epin
anta bisoprolol
b2 =
ag salbutamol
anta = propranolol
Receptors in a family may occur in different subtypes - similar structure but differences in their sequences, and in pharmacological properties.
Identified either:
- On the basis of selectivity of agonists and/or antagonists
- Or by cloning techniques
explain the different receptor subtypes for adrenoceptors
a1 =
ag epin
anta doxazosin
b1 =
ag epin
anta bisoprolol
b2 =
ag salbutamol
anta = propranolol
Receptors subtypes elicit many different cellular effects due to:
- different specificities for what activates or inhibits them and
- different signal transduction mechanisms
- Receptor with bound agonist is activated
- The activated receptor has altered physical and chemical properties
- This leads to changes within the cell to cause a biological response
Based on different molecular structure and signal transduction mechanisms, 4 receptor types which respond to drugs: LEGI
- Ligand gated ion channels
- G-protein coupled receptors
- Enzyme (kinase) linked receptors
- Intracellular receptors
Based on different molecular structure and signal transduction mechanisms, 4 receptor types which respond to drugs: LEGI
- Ligand gated ion channels
- G-protein coupled receptors
- Enzyme (kinase) linked receptors
- Intracellular receptors
Ligand gated ion channels = ionotropic receptors
work by :
ligand binds to the receptor, and a channel nearby opens up to allow ions in.
then it may cause
hyperpolarisation
or depolarisation of the cell, and then cellular effects.
G-protein coupled receptors = metabotropic
work by :
GPCR’s have 7 transmembrane alpha helices, with a binding site.
interact with g proteins. all g proteins have 3 subunits. alpha beta and gamma. Specificity of response is achieved through molecular variation in α subunits -
α subunits variation gives rise to 3 main families of G-protein
Galpha-s, Galpha-i, Gq
alpha and gamma are attached by lipid anchors to the CSM.
inactive protein means it binds GDP to alpha subunit.
when ligand binds –> conformational change.
when it is activated Gs protein releases GDP and binds GTP.
alpha subunit of Gs protein dissociates and regulates target proteins/activates adenylylcyclase –> catalyze formation of cAMP from ATP. cAMP is a second messenger.
target protein can relay a signal.
when hormone or drug is no longer present the receptor reverts to its resting state. GTP on alpha subunit is hydrolyzed to GDP, and adenylyl cylase is deactivated
eg adrenoceptors are types of GPCRs.
Explain how in G-protein signal transduction there are different alpha subunit variations in the G protein which give different responses:
Galpha-s = stimulatory
Activates adenylyl cyclase Activates Ca2+ channels
Galpha-i =
inhibitory
Inhibits adenylyl cyclase
Activates K+ channels
Gq =
Activates phospholipase C
eg adrenoceptors are GPCR - explain mechanism
alpha 1 - Gq - activates PLC - vasoconstriction
alpha 2 - Gi - Inhibit
adenylyl cyclase
- Auto-inhibition of neurotransmitter release
beta 1 and 2 - Gs - Stimulate adenylyl cyclase - b1 Accelerated heart rate
- b2 Bronchodilation.